Denali Therapeutics Inc. (DNLI)

NMS – Real Time Price. Currency in USD

19.46

-0.21 (-1.07%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

331M

108M

Cost of goods sold

-15M

-8M

-17M

-7M

Gross Profit

-15M

-8M

314M

101M

Operating expenses (excl. COGS)

-541M

-494M

-511M

-442M

Operating Income

-555M

-502M

-197M

-341M

Non-operating income, total

43M

79M

52M

15M

Pretax income

-512M

-423M

-145M

-326M

Equity in earnings

Taxes

-102K

-68K

-30K

-21K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-513M

-423M

-145M

-326M

Denali Therapeutics Inc. (DNLI)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Denali Therapeutics Inc. (DNLI)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Denali Therapeutics Inc. (DNLI)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Denali Therapeutics Inc. (DNLI)

Income Statement (Annual)

Income Statement (Annual)